Showing 3161-3170 of 19322 results for "".
Do You Need to Provide a Good Faith Estimate for a Botox Treatment?
https://reachmd.com/topics/injectables/do-you-need-to-provide-a-good-faith-estimate-for-a-botox-treatment/35210/Recent updates from CMS still don’t mention aesthetics specifically, but there are indications that some aesthetic and dermatology services require a GFE.Safety Monitoring of Disease-Modifying Therapies in Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/safety-monitoring-of-disease-modifying-therapies-in-multiple-sclerosis/32085/Guidance in disease-modifying therapy selection and appropriate safety monitoring are important roles of the clinician caring for people with multiple sclerosis.NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
https://reachmd.com/programs/neurofrontiers/nkx019-a-potential-new-frontier-in-generalized-myasthenia-gravis-therapy/30066/Read about NKX019, a new CAR cell therapy that will soon enter clinical trials as a potential treatment for generalized myasthenia gravis.Health Effects of the Gulf Oil Spill
https://reachmd.com/programs/focus-on-disaster-medicine-and-preparedness/health-effects-of-the-gulf-oil-spill/5880/Long after the clean-up process from the Deepwater Horizon oil spill is complete along the Gulf of Mexico, we'll still be examining the health effects of this catastrophe. While there is a wealth of information on the health effects of specific contaminants, the effects are less known regarding mixtEmbracing the Diversifying Aesthetics Market
https://reachmd.com/ma-issues-index/2022-nov-dec/embracing-the-diversifying-aesthetics-market/35225/The aesthetics market is diversifying in terms of age, gender identity, and race and ethnicity.RENEU (A Study to Evaluate the Safety, Effectiveness, and Tolerability of Gomekli in Children Aged ≥2 Years and Adults with an Inoperable NF1-PN; NCT03962543)
https://reachmd.com/programs/practical-neurology/trials-in-2/35433/Christopher Moertel, MD, Medical Director of the Pediatric Neuro-Oncology and Neurofibromatosis Programs at the University of Minnesota provides an overview of the ReNeu clinical trial which evaluated the safety, effectiveness, and tolerability of Gomekli in children aged ≥2 years and adults.Isolated Distal DVT in Cancer Cells for Longer DOAC Treatment
https://reachmd.com/cme/pace-cme/isolated-distal-dvt-cancer-cells-longer-doac-treatment/16003/Here's a recap of the ONCO DVT trial, as presented at the 2023 ESC Congress.Boston Legal's Christian Clemenson on Aspergers II
https://reachmd.com/programs/clinicians-roundtable/boston-legals-christian-clemenson-on-aspergers-ii/1977/Can an actor teach us how to better undertand our patients? Christian Clemenson, who plays Jerry "Hands" Espenson on Boston Legal discusses his role as a chacter with Aspergers Syndrome with host Dr. Bill Rutenberg.Impact of Early Thimerosal Exposure on Children
https://reachmd.com/programs/clinicians-roundtable/impact-of-early-thimerosal-exposure-on-children/1698/Does early thimerosal exposure have negative psychological outcomes? Dr. Bill Rutenberg talks with William Thompson, the Lead Author of a recent NEJM published study, Early Thimerosal Exposure and Neuropsychological Outcomes at 7 to 10 Years.The Dose Matters: Optimizing Statin Intensity in ASCVD Management
https://reachmd.com/programs/cme/the-dose-matters-optimizing-statin-intensity-in-ascvd-management/35816/Join our experts for case-based episodes that focus on bridging the gap between rural health and cardiovascular disease. Experts will explore ASCVD prevention and treatment by reviewing patient risk factors and determining ASCVD risk reduction strategies. This activity is designed to empower healthc